X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs FDC LTD. - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. FDC LTD. WOCKHARDT LTD./
FDC LTD.
 
P/E (TTM) x -24.4 22.7 - View Chart
P/BV x 2.5 5.1 48.4% View Chart
Dividend Yield % 0.0 0.9 0.2%  

Financials

 WOCKHARDT LTD.   FDC LTD.
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-18
FDC LTD.
Mar-14
WOCKHARDT LTD./
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs1,012144 705.2%   
Low Rs53279 672.8%   
Sales per share (Unadj.) Rs355.947.6 748.2%  
Earnings per share (Unadj.) Rs-60.37.6 -792.2%  
Cash flow per share (Unadj.) Rs-46.89.0 -519.0%  
Dividends per share (Unadj.) Rs0.012.25 0.4%  
Dividend yield (eoy) %02.0 0.1%  
Book value per share (Unadj.) Rs257.847.5 542.4%  
Shares outstanding (eoy) m110.63177.83 62.2%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.22.3 92.7%   
Avg P/E ratio x-12.814.6 -87.6%  
P/CF ratio (eoy) x-16.512.3 -133.7%  
Price / Book Value ratio x3.02.3 127.9%  
Dividend payout %029.6 -0.1%   
Avg Mkt Cap Rs m85,37919,784 431.6%   
No. of employees `0006.3NA-   
Total wages/salary Rs m9,3711,221 767.8%   
Avg. sales/employee Rs Th6,295.0NM-  
Avg. wages/employee Rs Th1,498.3NM-  
Avg. net profit/employee Rs Th-1,066.3NM-  
INCOME DATA
Net Sales Rs m39,3698,459 465.4%  
Other income Rs m1,202394 305.5%   
Total revenues Rs m40,5718,852 458.3%   
Gross profit Rs m182,070 0.9%  
Depreciation Rs m1,495249 600.3%   
Interest Rs m2,55531 8,239.0%   
Profit before tax Rs m-2,8302,184 -129.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257606 42.4%   
Profit after tax Rs m-6,6691,353 -492.8%  
Gross profit margin %024.5 0.2%  
Effective tax rate %-9.127.7 -32.8%   
Net profit margin %-16.916.0 -105.9%  
BALANCE SHEET DATA
Current assets Rs m33,7964,355 776.0%   
Current liabilities Rs m26,9171,792 1,502.2%   
Net working cap to sales %17.530.3 57.7%  
Current ratio x1.32.4 51.7%  
Inventory Days Days7944 178.5%  
Debtors Days Days8925 361.8%  
Net fixed assets Rs m39,6643,025 1,311.2%   
Share capital Rs m553179 309.7%   
"Free" reserves Rs m27,9688,243 339.3%   
Net worth Rs m28,5228,453 337.4%   
Long term debt Rs m21,73111 203,094.4%   
Total assets Rs m81,62010,557 773.1%  
Interest coverage x-0.171.4 -0.2%   
Debt to equity ratio x0.80 60,191.7%  
Sales to assets ratio x0.50.8 60.2%   
Return on assets %-5.013.1 -38.4%  
Return on equity %-23.416.0 -146.1%  
Return on capital %-7.723.5 -32.6%  
Exports to sales %013.3 0.0%   
Imports to sales %03.3 0.0%   
Exports (fob) Rs mNA1,126 0.0%   
Imports (cif) Rs mNA283 0.0%   
Fx inflow Rs m9,8071,146 855.7%   
Fx outflow Rs m1,789355 503.4%   
Net fx Rs m8,019791 1,014.0%   
CASH FLOW
From Operations Rs m6841,485 46.1%  
From Investments Rs m6,302-620 -1,017.3%  
From Financial Activity Rs m-7,695-753 1,022.6%  
Net Cashflow Rs m-664113 -588.7%  

Share Holding

Indian Promoters % 74.5 68.9 108.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 4.7 48.9%  
FIIs % 7.7 7.5 102.7%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 19.0 81.1%  
Shareholders   67,757 23,730 285.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   NOVARTIS  ASTRAZENECA PHARMA  STRIDES SHASUN LTD  IPCA LABS  JUBILANT LIFE SCIENCES  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (1QFY19); Net Profit Down 81.4% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, WOCKHARDT LTD. has posted a net profit of Rs 862 m (down 81.4% YoY). Sales on the other hand came in at Rs 10 bn (up 13.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Sep 18, 2018 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS